|
Jun 29
|
OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025
|
|
Jun 25
|
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
|
|
Jun 24
|
Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT
|
|
May 1
|
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands
|
|
May 1
|
Q1 2025 OPKO Health Inc Earnings Call
|
|
May 1
|
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...
|
|
Apr 30
|
OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 30
|
OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates
|
|
Apr 30
|
OPKO Health: Q1 Earnings Snapshot
|
|
Apr 30
|
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
|
|
Feb 13
|
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
|
|
Feb 12
|
Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?
|
|
Oct 17
|
With 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders have a lot riding on the company's future
|
|
Oct 11
|
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
|
|
Jan 11
|
Shockwave Medical (SWAV) Surges 7.8%: Is This an Indication of Further Gains?
|
|
Jan 9
|
OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
|
|
Dec 7
|
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
|
|
Dec 6
|
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?
|
|
Nov 28
|
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
|
|
Nov 7
|
Q3 2023 OPKO Health Inc Earnings Call
|